ArticleBMC veterinary research2026
Delivery and uptake of free and liposome-encapsulated cholesterol-conjugated antisense oligonucleotides in Atlantic salmon sperm: insights from high-resolution imaging.
Article in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of efficient methods for large-scale delivery of antisense molecules to Atlantic salmon (Salmo salar L.) eggs remains a significant challenge, limiting the application of antisense technologies in salmon aquaculture at an industrial scale. This study aimed to establish a proof of concept for a non-invasive, accessible method for delivering antisense oligonucleotides (ASOs) to salmon eggs using sperm cells as a delivery vehicle. Salmon spermatozoa were incubated for 24 h at 4 °C with a fluorescently labeled and cholesterol-conjugated antisense morpholino oligonucleotide (MO) in two formulations: cholesterol-conjugated antisense morpholino free in solution (F-MO) and cholesterol-conjugated antisense morpholino encapsulated into liposomes (L-MO). The binding and internalization patterns of F-MO and L-MO in spermatozoa were evaluated using fluorescence super-resolution microscopy. Both F-MO and L-MO incubations resulted in fluorescent binding in nearly 100% of the sperm cells, with distinct preferences for the head and tail regions of the sperm membrane. Notably, L-MO demonstrated superior internalization into the sperm head, as evidenced by higher fluorescence intensity within the head region compared to F-MO. Fertilization trials confirmed the successful transfer of L-MO to the egg, as indicated by visible fluorescence in the zygote. Moreover, incubation with either MO formulation did not adversely affect fertilization success or embryonic development up to the “eyed stage” under the experimental set-up conditions. In summary, high-resolution microscopy revealed enhanced uptake and internalization of L-MO compared to F-MO, enabling delivery and visualization of fluorescence in the one-cell embryo post-fertilization. These findings highlight the potential of sperm cells as a viable delivery vehicle for non-invasive transfer of MO oligonucleotides to salmon eggs. However, further research is required to optimize this approach and evaluate its scalability. Thus, this study provides a foundation for the development of cost-effective and practical ASO-based technologies for application in salmon aquaculture.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.